Kaiser Health News
Meadows' potential role as "Trumpcare" spoiler -- is stirring concern in the White House and Congress.
States' policies differ about who, what to cover in Medicaid; Republicans' effort to shrink federal Medicaid spending could lock in the differences.
Matching system hinges on young doctors being available and ready to start caring for patients in July; programs can't risk having empty seats.
Report revived questions about Price's investments in healthcare companies would've benefitted from legislation he voted for, sponsored.
Marathon Pharmaceuticals' controversial $89,000-a-year drug spawned outrage, intense questioning from Congress; new price not yet disclosed.
Texas reduced the rate of unnecessary early delivery by as much as 14 percent, led to increase in the length of pregnancies by nearly a week.
Complaints about the bill from several senators suggest there are more than enough GOP "no" votes in that chamber to block its passage.
These requirements add to the ongoing controversy about whether all nonprofit hospitals do enough to deserve a tax break.
HSA provider HealthEquity has seen its share of prices rise by about 35 percent since the November election.
In the rush to legislate, some facts surrounding the bill have gotten, if not lost, a little buried.